Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T_reg cells

Affiliations

• ¹ Genentech Inc., South San Francisco, CA, USA.
• ² Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
• ³ Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain.
• ⁴ Yonsei Cancer Centre, Yonsei University College of Medicine, Seoul, South Korea.
• ⁵ Institut Bergonie CLCC Bordeaux, Bordeaux, France.
• ⁶ Faculty of Medicine, University of Bordeaux, Bordeaux, France.
• ⁷ Clínica Universidad de Navarra, CIMA Universidad de Navarra Pamplona, Pamplona, Spain.
• ⁸ Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
• ⁹ Genentech Inc., South San Francisco, CA, USA. [email protected].
• ¹⁰ Genentech Inc., South San Francisco, CA, USA. [email protected].